Biomendex develops innovative tissue regeneration solutions, focusing on Adaptos® bone graft substitutes for surgical and veterinary applications.

Biomendex

Biomendex | 1,094 followers on LinkedIn. For freedom to operate, join the story.  | We at Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Our invention, Adaptos®, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive.

Senior Business Advisor at Business Tampere

Tapio Siik

Chief Medical Officer at Mehiläinen Oy. Patient safety, sustainability and communications.

Kaisla Lahdensuo

Executive Vice President at Scanfert Group, CEO at Saari Chocolate

Robert Ashorn

CEO & Chairman

Olli Gestranius

Day 2 at @Eläinlääkäripäivät 2024 Biomendex commercial team also awailable tomorrow. #boneregeration #freedomtooperate #adaptos

We're extending to OMF segment as well...

We’re happy to offer veterinarians the opportunity to experience the benefits of Adaptos®vet bone graft substitute. Order your testing kit today and discover how Adaptos®vet can streamline surgical procedures, reduce complications, and improve outcomes for your animal patients. With Adaptos®vet, you can: ✅ Decrease surgery time and costs ✅ Improve treatment outcomes ✅ Operate with ease and efficiency Order a testing kit on our website: https://lnkd.in/dEyKaKhM #FreedomToOperate #Biomendex #Adaptos #Bonegraft #VeterinaryCare

We are delighted to receive such support while navigating the expansion into the US!

Biomendex will attend the Finnish Veterinary Congress (Eläinlääkäripäivät) at the Helsinki Fair Centre from November 13 to 15! This three-day event will feature a diverse program covering general veterinary topics, business and working life, hygiene, production animals, small animals, horses, and more. We look forward to connecting with veterinary professionals and sharing our latest innovations. See you in Helsinki! Connect with Minna Hakanen from Biomendex at the event. #FreedomToOperate #Biomendex #Adaptos #BoneGraft #Veterinary #Eläinlääkäripäivät

We're excited to announce our collaboration with Mayo Clinic to further develop our fully synthetic and biodegradable bone graft material, Adaptos®. This collaboration focuses on advancing Adaptos® for new indications, aiming for FDA approval in the U.S. market. "A significant milestone for the company. Through this collaboration, we gain valuable input from the fields leading surgeons to further develop our products, enhancing patient care and its efficiency. We extend our thanks to @Business Finland, whose networks facilitated the initial discussions for this collaboration," says Pasi Kankaanpää , CEO of Biomendex. Mayo Clinic has financial interests in the technology referenced in this post. The clinic uses the revenue it receives to support its nonprofit mission in patient care, education, and research. #Biomendex #MayoClinic #FreedomToOperate #Bonegraft #Adaptos #BoneRegeneration #SpinalFusion #Oral #Maxillofacial

Biomendex is heading to the 2024 American College of Veterinary Surgeons Summit! The 2024 ACVS Surgery Summit from October 23-26, 2024 in Phoenix, Arizona. The summit offers a unique opportunity for veterinary professionals to engage in specialized hands-on labs on October 23, followed by seminars and scientific abstracts from October 24-26. Join Kaarlo Paakinaho at the Greater Phoenix Convention Center to explore the latest advancements in veterinary surgery. More about ACVS: https://lnkd.in/dF3Erppg #FreedomToOperate #Biomendex #Adaptos #BoneGraft #Veterinary #ACVS

Biomendex has reached a milestone – 1,000 followers on LinkedIn! 🚀 A huge thank you to each of you for your continued support, engagement, and interest in our mission to drive innovation in healthcare. This achievement wouldn’t be possible without our amazing community of followers, partners, and industry peers. We look forward to continuing this journey together as we push the boundaries of medical technology! #FreedomToOperate #Biomendex #Adaptos #BoneGraft #Innovation

Biomendex will be attending the ESVOT 2024 European Society of Veterinary Orthopaedics and Traumatology conference in Lisbon, taking place from September 25-28, 2024, at the Lisbon Congress Centre (CCL). This event is a fantastic opportunity to explore the latest advancements in veterinary orthopedics and traumatology and share our solutions with the veterinary community. Our team is eager to engage with experts, exchange ideas, and continue our mission to enhance animal health through cutting-edge technology and research. If you're attending ESVOT 2024, we would love to connect! Minna Hakanen from Biomendex will attend the event - see you in Lisbon! More about ESVOT: https://lnkd.in/gzfiT26n #FreedomToOperate #Biomendex #Adaptos #BoneGraft #Veterinary #ESVOT2024 #ESVOT

BIOM

COM:BIOMENDEX

Biomendex

name

homepage url

country

linkedin url

crunchbase url

sector

industry

monthly webtraffic

stage

raised capital

Description

competitor of

Metrics